198 related articles for article (PubMed ID: 25061833)
1. Conversion, correction, and International Scale standardization: results From a Multicenter External Quality Assessment Study for BCR-ABL1 testing.
Griffiths M; Patton SJ; Grossi A; Clark J; Paz MF; Labourier E;
Arch Pathol Lab Med; 2015 Apr; 139(4):522-9. PubMed ID: 25061833
[TBL] [Abstract][Full Text] [Related]
2. Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.
White HE; Hedges J; Bendit I; Branford S; Colomer D; Hochhaus A; Hughes T; Kamel-Reid S; Kim DW; Modur V; Müller MC; Pagnano KB; Pane F; Radich J; Cross NC; Labourier E
Clin Chem; 2013 Jun; 59(6):938-48. PubMed ID: 23471097
[TBL] [Abstract][Full Text] [Related]
3. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations.
Ruiz MS; Sánchez MB; Vera Contreras YM; Agrielo E; Alonso M; Altuna ME; Anchordoqui MS; Asinari M; Bonetto ME; Camargo M; Giere I; González J; Granda Alacote AC; Guerra J; Gutiérrez M; Maldonado C; Makiya R; Manrique G; Monaco ME; Rozo JC; Santamaría C; Seravalle A; Zea O; Zubillaga MN; Mordoh J; Larripa I; Bianchini M
Clin Chem Lab Med; 2020 Nov; 58(12):2025-2035. PubMed ID: 32374276
[TBL] [Abstract][Full Text] [Related]
4. Standardization of BCR-ABL1 quantification on the international scale in China using locally developed secondary reference panels.
Zhang JW; Fu Y; Wu QS; Bao LH; Peng RX; Zhang R; Li JM
Exp Hematol; 2020 Jan; 81():42-49.e3. PubMed ID: 31863797
[TBL] [Abstract][Full Text] [Related]
5. A novel approach for BCR-ABL1 standardization to improve International Scale estimation.
Maes B; Bakkus M; Boeckx N; Boone E; Cauwelier B; Denys B; De Schouwer P; Devos T; El Housni H; Hillen F; Jacobs K; Lambert F; Louagie H; Maes MB; Meeus P; Moreau E; Nollet F; Peeters K; Saussoy P; Van Lint P; Vaerman JL; Vaeyens F; Vandepoele K; Vannuffel P; Ver Elst K; Vermeulen K; Bruyndonckx R;
Int J Lab Hematol; 2016 Dec; 38(6):674-684. PubMed ID: 27460189
[TBL] [Abstract][Full Text] [Related]
6. A review of the challenge in measuring and standardizing BCR-ABL1.
Yu S; Cui M; He X; Jing R; Wang H
Clin Chem Lab Med; 2017 Aug; 55(10):1465-1473. PubMed ID: 28222016
[TBL] [Abstract][Full Text] [Related]
7. Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation.
Zhen C; Wang YL
J Mol Diagn; 2013 Sep; 15(5):556-64. PubMed ID: 23876601
[TBL] [Abstract][Full Text] [Related]
8. International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: first report from India.
Balasubramanian P; Chendamarai E; Markose P; Fletcher L; Branford S; George B; Mathews V; Chandy M; Srivastava A
Acta Haematol; 2012; 127(3):135-42. PubMed ID: 22249155
[TBL] [Abstract][Full Text] [Related]
9. Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost?
Cayuela JM; Macintyre E; Darlington M; Abdelali RB; Fund X; Villarese P; Tulliez M; Raffoux E; Sigaux F; Réa D; Seror V
Haematologica; 2011 May; 96(5):664-71. PubMed ID: 21330326
[TBL] [Abstract][Full Text] [Related]
10. [Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR].
Larripa I; Ruiz MS; Gutiérrez M; Bianchini M
Medicina (B Aires); 2017; 77(1):61-72. PubMed ID: 28140313
[TBL] [Abstract][Full Text] [Related]
11. External quality assessment of p210 BCR-ABL1 transcript quantification by RT-qPCR: Findings and recommendations.
Fu Y; Zhang R; Wu Q; Zhang J; Bao L; Li J
Int J Lab Hematol; 2019 Feb; 41(1):46-54. PubMed ID: 30203581
[TBL] [Abstract][Full Text] [Related]
12. Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scale.
Mauté C; Nibourel O; Réa D; Coiteux V; Grardel N; Preudhomme C; Cayuela JM;
Clin Biochem; 2014 Sep; 47(13-14):1333-6. PubMed ID: 24915631
[TBL] [Abstract][Full Text] [Related]
13. [Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].
Sacha T; Zawada M; Czekalska S; Florek I; Mueller M; Gniot M; Jaźwiec B; Kyrcz-Krzemień S; Leszczyńska A; Lewandowski K; Matiakowska K; Solarska I; Stokłosa T; Skotnicki AB
Przegl Lek; 2010; 67(7):454-9. PubMed ID: 21387754
[TBL] [Abstract][Full Text] [Related]
14. Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization.
Cross NC; Hochhaus A; Müller MC
Ann Hematol; 2015 Apr; 94 Suppl 2():S219-25. PubMed ID: 25814088
[TBL] [Abstract][Full Text] [Related]
15. [A multicenter study on the validation of conversion factor for the conversion of BCR-ABL (P210) transcript levels to the international scale in chronic myeloid leukemia].
Qin Y; Lin Z; Cen J; Li X; Li Q; Cheng H; Geng S; Wang Y; Ma D; Qiao C; Li J; Li L; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):134-7. PubMed ID: 24606655
[TBL] [Abstract][Full Text] [Related]
16. Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease.
Jennings LJ; Smith FA; Halling KC; Persons DL; Kamel-Reid S;
Arch Pathol Lab Med; 2012 Jan; 136(1):33-40. PubMed ID: 22208485
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of BCR-ABL1 quantification: Xpert assay, a feasible solution to standardization concerns.
López-Jorge CE; Gómez-Casares MT; Jiménez-Velasco A; García-Bello MA; Barrios M; Lopez J; de la Iglesia S; Ramírez T; Sánchez G; Heiniger AI; Molero T
Ann Hematol; 2012 Aug; 91(8):1245-50. PubMed ID: 22526369
[TBL] [Abstract][Full Text] [Related]
18. Performance of two commercially available BCR-ABL1 quantification assays that use an international reporting scale.
Seo SH; Lee SJ; Park S; Kim MJ; Song JY; Ra EK; Cho SI; Kim HK; Yang MG; Kim JY; Park SS; Seong MW
Clin Chem Lab Med; 2016 Jul; 54(7):1157-60. PubMed ID: 26587743
[TBL] [Abstract][Full Text] [Related]
19. Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.
White HE; Salmon M; Albano F; Andersen CSA; Balabanov S; Balatzenko G; Barbany G; Cayuela JM; Cerveira N; Cochaux P; Colomer D; Coriu D; Diamond J; Dietz C; Dulucq S; Engvall M; Franke GN; Gineikiene-Valentine E; Gniot M; Gómez-Casares MT; Gottardi E; Hayden C; Hayette S; Hedblom A; Ilea A; Izzo B; Jiménez-Velasco A; Jurcek T; Kairisto V; Langabeer SE; Lion T; Meggyesi N; Mešanović S; Mihok L; Mitterbauer-Hohendanner G; Moeckel S; Naumann N; Nibourel O; Oppliger Leibundgut E; Panayiotidis P; Podgornik H; Pott C; Rapado I; Rose SJ; Schäfer V; Touloumenidou T; Veigaard C; Venniker-Punt B; Venturi C; Vigneri P; Vorkinn I; Wilkinson E; Zadro R; Zawada M; Zizkova H; Müller MC; Saussele S; Ernst T; Machova Polakova K; Hochhaus A; Cross NCP
Leukemia; 2022 Jul; 36(7):1834-1842. PubMed ID: 35614319
[TBL] [Abstract][Full Text] [Related]
20. Quality control methods for optimal BCR-ABL1 clinical testing in human whole blood samples.
Stanoszek LM; Crawford EL; Blomquist TM; Warns JA; Willey PF; Willey JC
J Mol Diagn; 2013 May; 15(3):391-400. PubMed ID: 23541592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
